233
233
Jan 7, 2013
01/13
by
CNBC
tv
eye 233
favorite 0
quote 0
i'm not as worried about the debt ceiling as everyone else because everyone else is worry good it. we got news, the big banks reached a settlement on the morning put-back issue with. fannie mae forking over $6.5 billion and selling back mortgages to fannie. and the problem gets put to bed. no more spending huge sums on legal bills, at least of the major ones i believe. no hear resign risks that makes investors to go to bed with this stock in their portfolio. and bank of america sold $200 billion in troublesome, i think, mortgage service rights to nationstar mortgage. the rights are confusing. suffice to say it was good for everybody. they sold these assets, and it's good for nsm and for bank of america. sure, all of the big banks and bank of america have run a lot lately. the stocks are still well off the all-time highs. and actually well off the highs of a couple of years ago. and i think as things get better in 2013, as people realize that so many of the worries that have held the banks down for so long are in the past, these stocks will continue to climb higher. the sector isn't
i'm not as worried about the debt ceiling as everyone else because everyone else is worry good it. we got news, the big banks reached a settlement on the morning put-back issue with. fannie mae forking over $6.5 billion and selling back mortgages to fannie. and the problem gets put to bed. no more spending huge sums on legal bills, at least of the major ones i believe. no hear resign risks that makes investors to go to bed with this stock in their portfolio. and bank of america sold $200...
189
189
Jan 8, 2013
01/13
by
CNBC
tv
eye 189
favorite 0
quote 0
fiscal cliff, debt ceiling, how about guys like kevin doing amazing things? exact sciences. if this comes true, in other words, the fda gives the permission, you can see how big this can be. i like this story. stay with cramer. so if you have a flat tire, dead battery, need a tow or lock your keys in the car, geico's emergency roadside assistance is there 24/7. oh dear, i got a flat tire. hmmm. uh... yeah, can you find a take where it's a bit more dramatic on that last line, yeah? yeah i got it right here. someone help me!!! i have a flat tire!!! well it's good... good for me. what do you think? geico. fifteen minutes could save you fifteen percent or more on car insurance. ♪ i don't wanna be right [ record scratch ] what?! it's not bad for you. it just tastes that way. [ female announcer ] honey nut cheerios cereal -- heart-healthy, whole grain oats. you can't go wrong loving it. officemax can help you drive supply costs... down... ...and down. just use your maxperks card and get a case of x-9 paper for only 1-cent after maxperks rewards. find thousands of big deals now..
fiscal cliff, debt ceiling, how about guys like kevin doing amazing things? exact sciences. if this comes true, in other words, the fda gives the permission, you can see how big this can be. i like this story. stay with cramer. so if you have a flat tire, dead battery, need a tow or lock your keys in the car, geico's emergency roadside assistance is there 24/7. oh dear, i got a flat tire. hmmm. uh... yeah, can you find a take where it's a bit more dramatic on that last line, yeah? yeah i got it...
196
196
Jan 11, 2013
01/13
by
CNBC
tv
eye 196
favorite 0
quote 0
declining oil prices and the debt ceiling negotiations and new revenue raised by taxing them. you know what? that's the same old, same old. i don't care. like kinder morgan. looking for an entry point. yield above 6%, and currently 5.77%. you know what? if it happens, before they report, i would pounce. bank of america reports on thursday morning. okay. could this be the breakout quarter for bac, b-a-c-. the funny thing about the market. when everyone expects something good, you tend not to go it. the stock super bowl momentarily. this is a long-term positive story that needs to be button weakness, it bothers me that the stock caught two -- not one, but two downgrades in the past week. as you will hear later, short term, some concern. that's just short term, though. citigroup, the first conference call from the new ceo. i will be listening to hear the strategy going forward. the last quarter was terrific, but the ceo got fired immediately after it in a weird and wild tenure. i think the story has calmed down. after the close, we'll get results from capital one. i bet we get on
declining oil prices and the debt ceiling negotiations and new revenue raised by taxing them. you know what? that's the same old, same old. i don't care. like kinder morgan. looking for an entry point. yield above 6%, and currently 5.77%. you know what? if it happens, before they report, i would pounce. bank of america reports on thursday morning. okay. could this be the breakout quarter for bac, b-a-c-. the funny thing about the market. when everyone expects something good, you tend not to go...
196
196
Jan 9, 2013
01/13
by
CNBC
tv
eye 196
favorite 0
quote 0
. >>> the relief, finally had positive action today, but we all know with the battles over the debt ceiling, we could be looking at very difficult moments over the next couple of months. and that's why all week we've been focusing on the noneconomic big jpmorgan health care conference starting on monday where biotech and pharma countries strut their stuff. this is a small billion dollar biopharma firm focused on neuroology. back in 2010, accorda received approval for a drug called emperia that helps people gain their ability to walk. talk about how horrible this disease is, but it is also a lucrative disease for those who are trying to combat it, why? because it's a lifelong chronic condition. at this point, though, accoacor has gotten all the low-hanging fruit. the really impressive thing about this story is they could have multiple implications. that's the holy grail of the drug business. right now acorda is conducting phase two studies seeing if it can work on people with cerebral palsy. half of them have mobility issues. these additional indications are still in the early stages of bein
. >>> the relief, finally had positive action today, but we all know with the battles over the debt ceiling, we could be looking at very difficult moments over the next couple of months. and that's why all week we've been focusing on the noneconomic big jpmorgan health care conference starting on monday where biotech and pharma countries strut their stuff. this is a small billion dollar biopharma firm focused on neuroology. back in 2010, accorda received approval for a drug called...
125
125
Jan 5, 2013
01/13
by
CNBC
tv
eye 125
favorite 0
quote 0
when you consider the fiscal cliff worries and the debt ceiling over hang gives people reason to be down beat in order to reset the bar so it can be easily beaten. [ boo ] it could make the earnings season the most difficult one in years. [ ghost ] >> that said, we're not quitters. we give you a game plan. we'll be listening for more than just quarterly reports next week. starting monday we'll try to get a read on one of my favorite groups and not that economically sensitive. the bio techs. we're doing it courtesy of the jp morgan pharma conference. it's the most important conference of the year. i love this group so much. the health care con fab. what are we listening to? you know what i want to hear? cellgene speaks at 11:00. they are located in summit new jersey and so am i. we stuck with this one through thick and thin. how many times did people desert it? we haven't. i think it's going to be a great 2013 story. then at 2:30 we look forward to hearing from a favorite who defied all expectations withdrawing the promising als drug due to lack of efficacy. the stock barely dropped. how
when you consider the fiscal cliff worries and the debt ceiling over hang gives people reason to be down beat in order to reset the bar so it can be easily beaten. [ boo ] it could make the earnings season the most difficult one in years. [ ghost ] >> that said, we're not quitters. we give you a game plan. we'll be listening for more than just quarterly reports next week. starting monday we'll try to get a read on one of my favorite groups and not that economically sensitive. the bio...
212
212
Jan 12, 2013
01/13
by
CNBC
tv
eye 212
favorite 0
quote 0
ceiling negotiations might include new revenue raised by taxing them. you know what, that's the same old-same old. i don't care about it. i like kinder morgan. i'm looking for an entry point for you. if the yield goes above 6%, currently 5.77%, you know what, if it happens before this they report i would pass. bank of america reports in 30. okay. could this be the break-out quarter for b-a-c, bac is back. a lot of people participating. when everyone is expecting something good, you tend not to get if. we're going to go over theton stock in the super bowl momentarily. be aware this is a long-term positive story that needs to be bought on weakness, including anything you might get from earnings. it bothers me that the stock put two downgrades in the last week. as you hear later, short-term, some concern. just short-term, though. we also hear from citigroup. this will be the first conference call from the new ceo, michael corbatt. i will hear about what the strategy is going forward. remember, the last quarter was terrific, but then they panned it, got fir
ceiling negotiations might include new revenue raised by taxing them. you know what, that's the same old-same old. i don't care about it. i like kinder morgan. i'm looking for an entry point for you. if the yield goes above 6%, currently 5.77%, you know what, if it happens before this they report i would pass. bank of america reports in 30. okay. could this be the break-out quarter for b-a-c, bac is back. a lot of people participating. when everyone is expecting something good, you tend not to...